American Herbal Products Association (AHPA) > News

McGuffin statement on Sen. Hatch retirement

DSHEA was a remarkable achievement, made possible in large part by Sen. Hatch’s persistence and hard work

American Herbal Products Association (AHPA) President Michael McGuffin issued the following statement regarding the retirement of Sen. Orrin Hatch (R-UT), a vocal dietary supplement advocate who helped shape the laws that regulate the industry.

Industry Coalition Reminds Consumers, Retailers, and Product Marketers that Dietary Supplements Cannot Claim to Treat Opioid Addiction

Industry trade associations have been consistent in taking strong positions against marketing dietary supplements for treatment or prevention of diseases

The dietary supplement industry is aware of growing concerns regarding significant negative health impacts associated with opioid addiction and abuse. The leading trade associations of the dietary supplement industry support the responsible marketing and use of health-promoting vitamins, minerals, herbs, sports nutrition, and other dietary supplements.

FDA Inspection Trends, cGMP Compliance Issues and Responding to an FDA 483

Recorded Nov. 30 and Dec. 14

This two-part webinar provides an update on the elements of current Good Manufacturing Practice (cGMP) regulations (21 CFR 111) that have been the primary focus of recent FDA inspections. Experts also provide strategies to respond to an FDA 483 in order to avoid a warning letter.

AHPA mourns the passing of Jim Duke, a leading authority on herbal medicine

Bestselling author of The Green Pharmacy made invaluable contributions to the herbal community

AHPA was saddened to learn of the passing of James (Jim) A. Duke, Ph.D, a leading authority on herbal medicine who made invaluable contributions to the herbal products community.

AHPA submits comments on pre-DSHEA dietary ingredient list

AHPA recommended that FDA make significant changes to previous positions on new dietary ingredients (NDIs)

AHPA's comments were submitted in response to FDA's request for input on issues related to the future development of a list of dietary ingredients marketed in the United States prior to October 15, 1994, when the Dietary Supplement Health and Education Act (DSHEA) became law.

UNPA endorses AHPA's Good Agricultural and Collection Practices and Good Manufacturing Practices for Botanical Material

UNPA will encourage member companies to adopt AHPA's guidance

UNPA is the most recent association to endorse AHPA's guidance. The guidance has also been endorsed by the Council for Responsible Nutrition (CRN) and Consumer Healthcare Products Association (CHPA).

The most common FDA cGMP inspection observations of 2016-17

Data suggests inspections and compliance continues to increase

Data from the most recent FDA inspections of dietary supplement facilities conducted in 2016 and 2017 show FDA continues to inspect an increasing number of facilities annually and the industry continues to get better at communicating compliance to FDA inspectors.

IADSA update on international supplement regulations

IADSA November 2017 Newsflash

This issue of the IADSA Newsflash includes an overview of Thailand expanding its list of botanicals allowed to be used in supplements, China's plan to take enforcement action against fraudulent and illegal health claims and New Zealand and Australia legalizing hemp seeds as a food.

Supplement associations endorse AHPA's Good Agricultural and Collection Practices and Good Manufacturing Practices for Botanical Material

CRN and CHPA voice support for AHPA's new guidance

AHPA's Good Agricultural Collection Practices and Good Manufacturing Practices for Botanical Material (GACP-GMP) has been endorsed by the Consumer Healthcare Products Association (CHPA) and the Council for Responsible Nutrition (CRN).

Dietary Supplement Industry and U.S. Anti-Doping Agency Warn Consumers about Dangerous, Illegal Ingredients Known as SARMs

Groups support strict enforcement action by FDA

The dietary supplement industry’s leading trade associations and the U.S. Anti-Doping Agency (USADA) today joined in support of the U.S. Food and Drug Administration’s (FDA) recent actions to protect consumers from body-building products containing Selective Androgen Receptor Modulators (SARMs) illegally marketed as dietary supplements.

Alerts

Subscribe>>

AHPA Alerts

Subscribe >>

Recent News